Myasthenia gravis

By J. A. rd, R. Barohn, R. Ernstoff, H. Kaminski, J. Keesey, A. Penn, D. Sanders. Neurology, 2000

1,195 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Neurology, Surgery

View Paper: https://www.semanticscholar.org/paper/e03e33b1e74ecfea307b28f14b4e5a5fafa42d9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Padua
2. M. Marino
3. A. Batocchi
4. F. Scuderi
5. P. Tonali
6. A. Evoli
7. M. Monaco
8. E. Bartoccioni

Citations in the corpus

• Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. (2003, methodology): “Differences in disease severity between these patient groups are reproduced well by the MGFA grading system, which distinguishes, in patients with mild, moderate or severe MG, the site (limb or bulbar muscles) prevalently involved (Jaretzki et al., 2000).”